Carlyle Group Inc.

Q1 2023 13F-HR Holdings

Location
Washington, DC
Holdings as of
3/31/2023
Date filed
5/5/2023
Form type
13F-HR
Num holdings
30
Total value ($000)
$3,352,223
Net value change ($000)
-84,736 (-2.5%)
New positions
19
Sold out positions
2
Turnover %
14.8%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/10/2023 Next filing: 8/4/2023 SEC filing

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PCVX 72,080 NEW
VRNA 49,347 NEW
QDEL 42,614 4.0%
MKSI 32,998 4.6%
HilleVax, Inc. 30,096 NEW
VERA 22,883 NEW
PHAT 20,869 NEW
JSPR 15,771 NEW
INVH 14,912 NEW
OKUR 12,236 NEW
Top Reduces (Value $000, Stocks/ETFs)
1Life Healthcare Inc -227,468 -100.0%
GTM -197,977 -17.9%
GETY -5,476 -8.3%
GDS -1,895 -2.4%
SMHI -961 -8.8%
SPNT -764 -100.0%
EM -145 -2.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type